Loading
Latest filing published 03 Jul 2014 for Rennova Health, Inc., €3,584.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Carl Muscari appears in our data through filings on Rennova Health, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 26 March 2013 and the latest from 23 June 2014.
Purchases make up the whole of the open-market record (3 purchases, €11k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2014 alone, the filings show 1 purchase and no sales.
The median purchase comes to €3,721.
On 3 July 2014 came the latest disclosure, an open-market purchase for €3,584 in Rennova Health, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations